Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Karen L. Zaderej currently holds 40,000 shares of EyePoint Pharmaceuticals, Inc. (EYPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen L. Zaderej has been a net seller of EYPT stock. They have purchased $1.3M and sold $3.5M worth of shares.
Karen L. Zaderej's most recent insider trade was on Jan 2, 2026, when they sold 40,000 shares at $0.00 per share.
Karen L. Zaderej serves as Executive at EyePoint Pharmaceuticals, Inc. (EYPT). They have executed 95 insider transactions totaling $4.7M over their tenure at the company.
Karen L. Zaderej holds the position of Executive at EyePoint Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Karen L. Zaderej has shown a selling trading pattern, with $1.3M in total purchases and $3.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Karen L. Zaderej was on Jan 8, 2021, when they sold $1.3M worth of AXGN shares. This transaction involved 65,000 shares at $20.00 per share.
Karen L. Zaderej currently owns 40,000 shares of EyePoint Pharmaceuticals, Inc. (EYPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Karen L. Zaderej's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Karen L. Zaderej has 95 Form 4 filings on record as an insider at EyePoint Pharmaceuticals, Inc..
Set alerts for Karen L. Zaderej and 40,000+ other insiders.